Neonatal Pain

3

Review clinical trials related to Neonatal Pain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants

The goal of this clinical trial is to learn whether intranasal fentanyl (a pain medicine given as a nasal spray) can reduce pain and is safe to use during routine eye examinations for retinopathy of prematurity (ROP) in preterm infants. ROP is an eye condition that can affect babies born too early and requires regular eye examinations. The main questions this study aims to answer are: Does intranasal fentanyl lower pain during ROP screening? Is intranasal fentanyl safe for preterm infants? Researchers will compare intranasal fentanyl with a placebo (a saltwater spray that contains no medicine) to determine whether the medicine lowers pain during ROP screening. Participants will receive either intranasal fentanyl or placebo before their routine ROP eye examination, in addition to the standard comfort measures normally used during the procedure. Researchers will measure participants' pain and monitor their heart rate, oxygen levels, and any side effects during and after the examination.

Participants needed: 58
Trial details
Phase: Phase 1, Phase 2Biological sex: AllType: InterventionalSponsor: Marsha Campbell-YeoUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Preterm infants born ≤31 weeks gestational age and/or with birth weight <1250 g [+3]

Congenital anomalies or conditions affecting the nasal passages that would inter... [+2]

Status: Not yet recruiting

MOTHER3SENSE Study

This randomized controlled trial aims to compare the effects of maternal voice, touch, and scent on pain and stress levels in newborns during a routine heel lance procedure. Newborns will be randomly assigned to one of three intervention groups or a control group. Pain and stress responses will be assessed using validated neonatal pain and physiological measures. The findings of this study may help identify effective, low-cost, and non-pharmacological interventions that can be used to reduce pain and stress in newborns during routine clinical procedures.

Participants needed: 120
Trial details
Age: 0-28Biological sex: AllType: InterventionalSponsor: Kilis 7 Aralik UniversityUpdated: Jun 16, 2026Locations: 1
Eligibility criteria

Term newborns born between 37 and 42 weeks of gestation [+6]

Preterm (<37 weeks) or post-term (>42 weeks) newborns [+5]

Status: Recruiting

ShotBlocker During Intramuscular Injection Randomized Control Trial

The objective of this trial is to evaluate the effect of Bionix ShotBlocker on pain of injection of the first Hepatitis B vaccine in healthy newborns. ShotBlocker is a pain reducing tool used in babies, children, and adults for injections. Swaddling during the injection and administration of oral sucrose prior to the injection are established standards of care for painful procedures in neonates. The investigators hypothesize that the use of ShotBlocker in addition to swaddling and oral sucrose administration will lessen the pain response.

Participants needed: 200
Trial details
Age: 37-42Biological sex: AllType: InterventionalSponsor: Lauren FortierUpdated: Jun 4, 2026Locations: 1
Eligibility criteria

Infants born at UMass Memorial Medical Center (UMMMC) via vaginal delivery or ce... [+6]

Swallow dysfunction [+6]